VERTEX PHARMACEUTICALS INC / MA (NASDAQ:VRTX) filed its annual report (Form 10-K) with the Securities and Exchange Commission on February 13, 2026. The Healthcare company reported…
VERTEX PHARMACEUTICALS INC / MA (NASDAQ:VRTX) filed its annual report (Form 10-K) with the Securities and Exchange Commission on February 13, 2026.
The Healthcare company reported annual revenue of and net income of for fiscal year 0.
VERTEX PHARMACEUTICALS INC / MA's stock currently trades at $491.47 with a market capitalization of $114.5B.
Current market data
NASDAQ · VRTX
$548.05
Up: +$7.79 · +1.44%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
price ·
analyst ·
analyst ·
analyst ·
